[H1NI]), A/PC (A/Port Chalmers/l/73 [H3N2]), and a recombinant virus A/X31 (H3N2), were propagated in 9-d-old embryonated chicken eggs, as described previously (9) .
Production ofcl3 Protein. c13 protein was produced in E. coli as described before (9) .
Briefly, plasmids containing DNA fragments complementary to the viral RNA of PR8 virus were manipulated to achieve expression of c 13 protein, which is a hybrid of the first 81 amino acids of NSl and HA2. Following lysis of the bacteria, two 0.1% deoxycholate extractions and one 1% Triton X-100 extraction were performed to remove contaminating E. coli proteins, and the c13 protein was solubilized with 4 M urea (4°C for 30 rain).
The urea was then removed by dialysis at 4°C and stored in 50 mM Tris-HCl, pH 8.0, 1 mM EDTA. Induction of Secondary CTL In Vitro. Secondary CTL were prepared as described previously (9) . Briefly, spleen cells from mice immunized with virus were cultured with syngeneic normal spleen cells infected with the virus or exposed to c13 protein (12.5 #g/ml) at 37°C for 5 d. After several washings, they were used as effector cells. CTL Assay. P815 cells (H-2 d) and BW5147 cells (H-2 k) were used as target cells. In preliminary experiments, we observed that P815 and BW5147 cells exposed to c13 protein (12 ~g/ml) expressed membrane antigen(s), detected by indirect immunofluorescence with a specific antiserum to c13 protein, but P815 and BW5147 cells not treated with c13 did not. In the CTL assay, target cells infected with virus, or exposed to c13 protein diluted in RPMI medium, were labeled with Na25~CrO4, and incubated with effector cells at various effector/target (E/T) ratios in a 96-well round-bottom microplate at 37°C for 4 h in a standard 51Cr-release assay, as described earlier (9) .
Cold-target Inhibition Test. P815 cells infected with various viruses or treated with c 13
protein (12.5 t~g/ml) at 37°C for 90 min were added to the CTL assay at various concentrations. The CTL assay was performed as described below.
Blocking of Cytotoxicity by Anti-H-2 a Monoclonal Antibody (mAb).
Various target cells were incubated with anti-H-2 a mAb (Litton Bionetics, Charleston, SC) at 37°C for 30 rain, and then were incubated with appropriate effector cells at 37°C for 4 h. Antibody was used at 1:20 dilution (final), based on the results of a preliminary experiment. Cytotoxicity was determined as described above.
Results

Influenza Virus-specific Lysis of Target Cells Exposed to c13.
We examined the ability of c 13 protein to render P815 cells susceptible to influenza virus-specific CTL. Effector cells were generated by stimulation of PR8 virus-immune spleen cells with PR8 virus-infected syngeneic spleen cells, and by c13 protein. As shown in Fig. 1, c13 protein-coated P815 cells were lysed by PR8 virus-and c l 3 protein-induced CTL, although the level of lysis was below that of virusinfected target cells. The level of lysis of cl 3 protein-coated target cells was dose-dependent up to a concentration of 3 ~g/ml (data not shown). These results, (Fig. 1) suggested that target cells exposed to c 13 protein displayed an H 1 virus subtype-specific determinant, since c13 protein has been shown (9) to induce H1 subtype-specific CTL. We therefore prepared two different effector cells, PR8 virus-stimulated PR8 virus-immune spleen cells, and A/PC virus-stimulated A/PC virus-immune spleen cells. Both PR8-immune effectors and PCimmune effectors specifically lysed PR8 virus-infected target cells; (e.g., 63.8% and 66.2%, respectively, at E/T ratios of 10:1); however, c13 protein-coated target cells showed little lysis by A/PC virus-induced A/PC virus-immune spleen cells, (2.8% at E/T 10:1), whereas they were definitely susceptible to PR8 virusstimulated PR8 virus-immune spleen cells (34.0% at E/T 10:1). These findings suggest that c13 protein-coated target cells were lysed by PR8 virus-specific CTL, but not by either crossreactive or A/PC virus-specific CTL. to liposomes containing influenza virus surface glycoproteins, HA and neuraminidase (NA).
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As far as we know, there have been no successful reports of making target cells sensitive to CTL specific for viral proteins without using liposomes. In this regard, it was somewhat unexpected to observe killing of c13 protein-coated P815 cells. The HA2 portion of c 13 protein has a long hydrophobic tail on its carboxy-terminal end (11); therefore, it is conceivable that this hydrophobic end can be embedded into the plasma membrane, although we do not know the precise mechanism of the interaction of c 13 protein with the cellular membrane. The observation (12) that the tryptic peptide of hen's egg lysozyme, which has a hydrophobic portion, could be presented by fixed macrophages to T cell clones seems to support this concept.
The observation that C3H (H-2 k) mouse effector cells with the ability to lyse PR8 virus-infected BW5147 (H-2 k) cells did not lyse c13 protein-coated P815 (H-2 d) cells suggests that lysis of c13 protein-coated target cells was H-2 restricted. The association of c 13 protein with an H-2 molecule was also suggested by a blocking experiment using mAb against H-2K d and -D d molecules. On the other hand, it is of interest that c 13 protein-coated BW5147 cells were resistant to CTL derived from both H-2-compatible and -incompatible mice. Since c l 3 protein could be detected on the surface of BW5147 cells by immunofluorescent study using specific antibody to cl 3 protein (our unpublished observation), it is conceivable that influenza virus-specific, H-2k-restricted CTL cannot recognize c13 protein in conjunction with H-2 k molecules. Selected use of certain H-2 molecules as restriction elements by CTL has been reported (13) .
In conclusion, we have demonstrated that a particular protein produced in E. coli renders target cells susceptible to influenza virus H 1 subtype-specific CTL. These approaches should provide us with more details concerning the antigenic specificity of virus-specific CTL and the interaction between viral antigen(s) and MHC product(s). Summary We have tested the ability of the c 13 protein, which is a hybrid protein of the first 81 amino acids of the viral nonstructural protein (NS 1) and the HA2 subunit of viral hemagglutination produced in E. coli, to render target cells susceptible to the lytic activity of influenza virus-specific cytotoxic T lymphocytes (CTL). The results showed that P815 cells coated with c13 protein were lysed by PR8 virus-induced secondary CTL derived from BALB/c mice. Cold-target inhibition tests clearly demonstrated that c l 3 protein-coated P815 cells were recognized by an H1 subtype-specific CTL population. Furthermore, PR8 virusinduced CTL derived from C3H mice did not lyse c13 protein-coated P815 cells, suggesting that cl 3 protein was recognized by CTL in conjunction with H-2 d products. These findings suggest that this protein interacts with the cellular plasma membrane and makes target cells recognizable by H-2-restricted, influenza virus subtype-specific CTL.
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